|
| |
| | | 67281 | | 28.05.2020 | | Bayer (Schweiz) AG | | | | | | | 19.02.2029 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Vitrakvi 25 mg | Kapseln | Capsules (Larotrectinibum 25 mg) | L01EX12 | CI | | 02 | Vitrakvi 100 mg | Kapseln | Capsules (Larotrectinibum 100 mg) | L01EX12 | CI |
|
|
|